Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Cervical Cancer

  Free Subscription


20.03.2017

1 Ann Afr Med
1 BMC Public Health
1 BMC Womens Health
1 Can Fam Physician
1 Cancer Cell Int
1 Cancer Genet
1 Chin J Cancer
1 Cureus
1 Dan Med J
1 Eur J Nucl Med Mol Imaging
2 Eur J Obstet Gynecol Reprod Biol
1 Exp Mol Pathol
3 Genet Mol Res
1 Int J Cancer
1 Int J Mol Sci
1 Int J Oncol
8 J Appl Clin Med Phys
1 J Cell Biochem
1 J Drug Target
1 J Laparoendosc Adv Surg Tech A
7 J Low Genit Tract Dis
1 J Photochem Photobiol B
1 J Renin Angiotensin Aldosterone Syst
1 Med Oncol
1 Med Phys
1 Med Sci Monit Basic Res
1 MMWR Morb Mortal Wkly Rep
1 Narrat Inq Bioeth
2 Nucl Med Commun
1 Oncol Rep
2 Pathol Int
1 Pathol Res Pract
1 Pharm Biol
1 Phys Med Biol
6 Prev Med
1 Radiology
1 Recent Pat Anticancer Drug Discov
1 Sci Rep
1 Virus Genes


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Afr Med

  1. OGBONNA FS
    Knowledge, attitude, and experience of cervical cancer and screening among Sub-saharan African female students in a UK University.
    Ann Afr Med. 2017;16:18-23.
    PubMed     Text format     Abstract available


    BMC Public Health

  2. NDEJJO R, Mukama T, Musinguzi G, Halage AA, et al
    Women's intention to screen and willingness to vaccinate their daughters against cervical cancer - a cross sectional study in eastern Uganda.
    BMC Public Health. 2017;17:255.
    PubMed     Text format     Abstract available


    BMC Womens Health

  3. IDEHEN EE, Korhonen T, Castaneda A, Juntunen T, et al
    Factors associated with cervical cancer screening participation among immigrants of Russian, Somali and Kurdish origin: a population-based study in Finland.
    BMC Womens Health. 2017;17:19.
    PubMed     Text format     Abstract available


    Can Fam Physician

  4. YANG DY, Bracken K
    Update on the new 9-valent vaccine for human papillomavirus prevention.
    Can Fam Physician. 2016;62:399-402.
    PubMed     Text format     Abstract available


    Cancer Cell Int

  5. HU Y, Xie H, Liu Y, Liu W, et al
    miR-484 suppresses proliferation and epithelial-mesenchymal transition by targeting ZEB1 and SMAD2 in cervical cancer cells.
    Cancer Cell Int. 2017;17:36.
    PubMed     Text format     Abstract available


    Cancer Genet

  6. TAN SC, Ismail MP, Duski DR, Othman NH, et al
    FAS c.-671A>G polymorphism and cervical cancer risk: a case-control study and meta-analysis.
    Cancer Genet. 2017;211:18-25.
    PubMed     Text format     Abstract available


    Chin J Cancer

  7. WANG XJ, Xiong Y, Ma ZB, Xia JC, et al
    The expression and prognostic value of protein tyrosine kinase 6 in early-stage cervical squamous cell cancer.
    Chin J Cancer. 2016;35:54.
    PubMed     Text format     Abstract available


    Cureus

  8. AL KHUDAIRI H, Abu-Zaid A, Alomar O, Salem H, et al
    Public Awareness and Knowledge of Pap Smear as a Screening Test for Cervical Cancer among Saudi Population in Riyadh City.
    Cureus. 2017;9:e984.
    PubMed     Text format     Abstract available


    Dan Med J

  9. SORENSEN T, Andersen PT
    A qualitative study of women who experience side effects from human papillomavirus vaccination.
    Dan Med J. 2016;63.
    PubMed     Text format     Abstract available


    Eur J Nucl Med Mol Imaging

  10. SCARSBROOK A, Vaidyanathan S, Chowdhury F, Swift S, et al
    Efficacy of qualitative response assessment interpretation criteria at 18F-FDG PET-CT for predicting outcome in locally advanced cervical carcinoma treated with chemoradiotherapy.
    Eur J Nucl Med Mol Imaging. 2017;44:581-588.
    PubMed     Text format     Abstract available


    Eur J Obstet Gynecol Reprod Biol

  11. AYHAN A, Tuncer HA, Reyhan NH, Kuscu E, et al
    Risk factors for residual disease after cervical conization in patients with cervical intraepithelial neoplasia grades 2 and 3 and positive surgical margins.
    Eur J Obstet Gynecol Reprod Biol. 2016;201:1-6.
    PubMed     Text format     Abstract available

  12. SHERMAN SM, Moss EL, Pearmain P, Redman CW, et al
    Colposcopists' experiences of HPV Test of Cure for the follow up of cervical intra-epithelial neoplasia.
    Eur J Obstet Gynecol Reprod Biol. 2016;201:42-5.
    PubMed     Text format     Abstract available


    Exp Mol Pathol

  13. KIM G, Cho H, Lee D, Park S, et al
    Comparison of FFPE histological versus LBP cytological samples for HPV detection and typing in cervical cancer.
    Exp Mol Pathol. 2017;102:321-326.
    PubMed     Text format     Abstract available


    Genet Mol Res

  14. ZHANG HM, Chen SQ, Yao SZ
    Expression and clinical implications of enhancer of Zeste homolog 2 and p53 protein in squamous cell carcinoma and precancerous lesions in the cervix.
    Genet Mol Res. 2016;15.
    PubMed     Text format     Abstract available

  15. HE CY, Yang J
    miR-187 induces apoptosis of SiHa cervical carcinoma cells by downregulating Bcl-2.
    Genet Mol Res. 2017;16.
    PubMed     Text format     Abstract available

  16. ZHANG L, Niyazi HE, Zhao HR, Cao XP, et al
    Effects of miRNA-143 and the non-coding RNA MALAT1 on the pathogenesis and metastasis of HeLa cells.
    Genet Mol Res. 2017;16.
    PubMed     Text format     Abstract available


    Int J Cancer

  17. MEZEI AK, Armstrong HL, Pedersen HN, Campos NG, et al
    Cost-effectiveness of cervical cancer screening methods in low- and middle-income countries: a systematic review.
    Int J Cancer. 2017 Mar 15. doi: 10.1002/ijc.30695.
    PubMed     Text format     Abstract available


    Int J Mol Sci

  18. VORSTERS A, Van Keer S, Biesmans S, Hens A, et al
    Long-Term Follow-up of HPV Infection Using Urine and Cervical Quantitative HPV DNA Testing.
    Int J Mol Sci. 2016;17.
    PubMed     Text format     Abstract available


    Int J Oncol

  19. SUN L, Xia WY, Zhao SH, Liu N, et al
    An asymmetrically dimethylarginated nuclear 90 kDa protein (p90aDMA) induced by interleukin (IL)-2, IL-4 or IL-6 in the tumor microenvironment is selectively degraded by autophagy.
    Int J Oncol. 2016;48:2461-71.
    PubMed     Text format     Abstract available


    J Appl Clin Med Phys

  20. KIM Y, Modrick JM, Pennington EC, Kim Y, et al
    Commissioning of a 3D image-based treatment planning system for high-dose-rate brachytherapy of cervical cancer.
    J Appl Clin Med Phys. 2016;17:405-426.
    PubMed     Text format     Abstract available

  21. DENG X, Han C, Chen S, Xie C, et al
    Dosimetric benefits of intensity-modulated radiotherapy and volumetric-modulated arc therapy in the treatment of postoperative cervical cancer patients.
    J Appl Clin Med Phys. 2017;18:25-31.
    PubMed     Text format     Abstract available

  22. FENG CH, Hasan Y, Kopec M, Al-Hallaq HA, et al
    Simultaneously integrated boost (SIB) spares OAR and reduces treatment time in locally advanced cervical cancer.
    J Appl Clin Med Phys. 2016;17:1-12.
    PubMed     Text format     Abstract available

  23. WAN B, Lang J, Wang P, Ma CM, et al
    Treatment optimization with concurrent SBRT and intracavitary brachytherapy for locally advanced cervical cancer.
    J Appl Clin Med Phys. 2016;17:70-79.
    PubMed     Text format     Abstract available

  24. LEE B, Ahn SH, Kim H, Son J, et al
    Secondary cancer-incidence risk estimates for external radiotherapy and high-dose-rate brachytherapy in cervical cancer: phantom study.
    J Appl Clin Med Phys. 2016;17:1-9.
    PubMed     Text format     Abstract available

  25. GOYAL MK, Rai DV, Kehwar TS, Manjhi J, et al
    Anatomy-based definition of point A utilizing three-dimensional volumetric imaging approach for high-dose-rate (HDR) intracavitary brachytherapy dose prescription when treating cervical cancer using limited resources.
    J Appl Clin Med Phys. 2016;17:69-77.
    PubMed     Text format     Abstract available

  26. MEERSCHAERT R, Nalichowski A, Burmeister J, Paul A, et al
    A comprehensive evaluation of adaptive daily planning for cervical cancer HDR brachytherapy.
    J Appl Clin Med Phys. 2016;17:323-333.
    PubMed     Text format     Abstract available

  27. CHANG L, Ho SY, Yeh SA, Lee TF, et al
    An innovative method to acquire the location of point A for cervical cancer treatment by HDR brachytherapy.
    J Appl Clin Med Phys. 2016;17:434-445.
    PubMed     Text format     Abstract available


    J Cell Biochem

  28. BAHRAMI A, Hasanzadeh M, ShahidSales S, Yousefi Z, et al
    Clinical Significance and Prognosis Value of Wnt Signaling Pathway in Cervical Cancer.
    J Cell Biochem. 2017 Mar 16. doi: 10.1002/jcb.25992.
    PubMed     Text format     Abstract available


    J Drug Target

  29. SHEN CJ, Cheng YM, Wang CL
    LncRNA PVT1 epigenetically silences miR-195 and modulates EMT and chemoresistance in cervical cancer cells.
    J Drug Target. 2017 Mar 15:1-19. doi: 10.1080/1061186X.2017.1307379.
    PubMed     Text format     Abstract available


    J Laparoendosc Adv Surg Tech A

  30. ZHAO Y, Hang B, Xiong GW, Zhang XW, et al
    Laparoscopic Radical Hysterectomy in Early Stage Cervical Cancer: A Systematic Review and Meta-analysis.
    J Laparoendosc Adv Surg Tech A. 2017 Mar 16. doi: 10.1089/lap.2017.0022.
    PubMed     Text format     Abstract available


    J Low Genit Tract Dis

  31. SYKES P, Innes C, Harker D, Whitehead M, et al
    Observational Management of CIN 2 in Young Women: A Prospective Multicenter Trial.
    J Low Genit Tract Dis. 2016;20:343-7.
    PubMed     Text format     Abstract available

  32. DOO DW, Stickrath EH, Mazzoni SE, Alston MJ, et al
    Lack of Agreement Between Endocervical Brush and Endocervical Curettage in Women Undergoing Repeat Endocervical Sampling.
    J Low Genit Tract Dis. 2016;20:296-9.
    PubMed     Text format     Abstract available

  33. KUROKI LM, James-Nywening L, Wu N, Liu J, et al
    High-Grade Cervical Dysplasia After Negative Loop Electrosurgical Excision Procedure.
    J Low Genit Tract Dis. 2016;20:300-6.
    PubMed     Text format     Abstract available

  34. SOARES LC, de Oliveira MA
    Cervical Adenocarcinoma: Are We Screening and Treating Patients Appropriately?
    J Low Genit Tract Dis. 2016;20:352-3.
    PubMed     Text format    

  35. LANDERS EE, Erickson BK, Bae S, Huh WK, et al
    Trends in Colposcopy Volume: Where Do We Go From Here?
    J Low Genit Tract Dis. 2016;20:292-5.
    PubMed     Text format     Abstract available

  36. UCAR MG, Ilhan TT, Ucar RM, Karabagli P, et al
    Diagnostic Value of Visual Examination of Cervical Polypoid Lesions and Predictors of Misdiagnosis.
    J Low Genit Tract Dis. 2016;20:356-9.
    PubMed     Text format     Abstract available

  37. BELINSON JL, Pretorius RG
    A Standard Protocol for the Colposcopy Exam.
    J Low Genit Tract Dis. 2016;20:e61-2.
    PubMed     Text format    


    J Photochem Photobiol B

  38. GAIO E, Scheglmann D, Reddi E, Moret F, et al
    Uptake and photo-toxicity of Foscan(R), Foslip(R) and Fospeg(R) in multicellular tumor spheroids.
    J Photochem Photobiol B. 2016;161:244-52.
    PubMed     Text format     Abstract available


    J Renin Angiotensin Aldosterone Syst

  39. YUE Z, Yun-Shan Z, Feng-Xia X
    miR-205 mediates the inhibition of cervical cancer cell proliferation using olmesartan.
    J Renin Angiotensin Aldosterone Syst. 2016;17:1470320316663327.
    PubMed     Text format     Abstract available


    Med Oncol

  40. BEN-ARYE E, Lavie O, Samuels N, Khamaisie H, et al
    Safety of herbal medicine use during chemotherapy in patients with ovarian cancer: a "bedside-to-bench" approach.
    Med Oncol. 2017;34:54.
    PubMed     Text format     Abstract available


    Med Phys

  41. MEADOWS JL, Bichay TJ
    Low dose-rate brachytherapy for the treatment of cervix cancer is outdated and should be discontinued.
    Med Phys. 2016;43:4963.
    PubMed     Text format    


    Med Sci Monit Basic Res

  42. LIU L, Zhan P, Nie D, Fan L, et al
    Intermediate-Conductance-Ca2-Activated K Channel Intermediate-Conductance Calcium-Activated Potassium Channel (IKCa1) is Upregulated and Promotes Cell Proliferation in Cervical Cancer.
    Med Sci Monit Basic Res. 2017;23:45-57.
    PubMed     Text format     Abstract available


    MMWR Morb Mortal Wkly Rep

  43. WHITE A, Thompson TD, White MC, Sabatino SA, et al
    Cancer Screening Test Use - United States, 2015.
    MMWR Morb Mortal Wkly Rep. 2017;66:201-206.
    PubMed     Text format     Abstract available


    Narrat Inq Bioeth

  44. BUSTILLOS D
    Political Pitfalls in Policymaking: The Texas HPV Vaccine Policy Saga.
    Narrat Inq Bioeth. 2016;6:6-10.
    PubMed     Text format    


    Nucl Med Commun

  45. XU W, Yu S, Ma Y, Liu C, et al
    Effect of different segmentation algorithms on metabolic tumor volume measured on 18F-FDG PET/CT of cervical primary squamous cell carcinoma.
    Nucl Med Commun. 2017 Jan 21. doi: 10.1097/MNM.0000000000000641.
    PubMed     Text format     Abstract available

  46. VOGEL WV, Bloemers MC, van der Heide UA, Beets-Tan RG, et al
    Accuracy of PET/MRI coregistration of cervical lesions.
    Nucl Med Commun. 2016;37:997-8.
    PubMed     Text format    


    Oncol Rep

  47. ZHANG X, Cai D, Meng L, Wang B, et al
    MicroRNA-124 inhibits proliferation, invasion, migration and epithelial-mesenchymal transition of cervical carcinoma cells by targeting astrocyte-elevated gene-1.
    Oncol Rep. 2016;36:2321-8.
    PubMed     Text format     Abstract available


    Pathol Int

  48. TAGUCHI R, Higuchi K, Sudo M, Misawa K, et al
    A case of anaplastic lymphoma kinase (ALK)-positive ciliated muconodular papillary tumor (CMPT) of the lung.
    Pathol Int. 2017;67:99-104.
    PubMed     Text format     Abstract available

  49. TSIAMBAS E, Riziotis C
    Implementation of a real-time reference and calibration grid platform for improved screening - mapping in Pap test slides.
    Pathol Int. 2017;67:24-31.
    PubMed     Text format     Abstract available


    Pathol Res Pract

  50. SHAFIEI-JANDAGHI NZ, Yavarian J, Faghihloo E, Ghavami N, et al
    Prevalence of adeno-associated virus and human papillomavirus DNA in Iranian women with and without cervical cancer.
    Pathol Res Pract. 2017 Feb 24. pii: S0344-0338(16)30364.
    PubMed     Text format     Abstract available


    Pharm Biol

  51. IBRAHIM M, Kaushik N, Sowemimo A, Chhipa H, et al
    Antifungal and antiproliferative activities of endophytic fungi isolated from the leaves of Markhamia tomentosa.
    Pharm Biol. 2017;55:590-595.
    PubMed     Text format     Abstract available


    Phys Med Biol

  52. RAO YJ, Zoberi JE, Kadbi M, Grigsby PW, et al
    Metal artifact reduction in MRI-based cervical cancer intracavitary brachytherapy.
    Phys Med Biol. 2017;62:3011-3024.
    PubMed     Text format     Abstract available


    Prev Med

  53. TOTA JE, Bentley J, Blake J, Coutlee F, et al
    Introduction of molecular HPV testing as the primary technology in cervical cancer screening: Acting on evidence to change the current paradigm.
    Prev Med. 2017;98:5-14.
    PubMed     Text format     Abstract available

  54. WENTZENSEN N, Arbyn M
    HPV-based cervical cancer screening- facts, fiction, and misperceptions.
    Prev Med. 2017;98:33-35.
    PubMed     Text format     Abstract available

  55. KINNEY WK, Huh WK
    Protection against cervical cancer versus decreasing harms from screening - What would U.S. patients and clinicians prefer, and do their preferences matter?
    Prev Med. 2017;98:31-32.
    PubMed     Text format     Abstract available

  56. SCHIFFMAN M
    Cervical cancer screening: Epidemiology as the necessary but not sufficient basis of public health practice.
    Prev Med. 2017;98:3-4.
    PubMed     Text format    

  57. TOTA JE, Bentley J, Blake J, Coutlee F, et al
    Approaches for triaging women who test positive for human papillomavirus in cervical cancer screening.
    Prev Med. 2017;98:15-20.
    PubMed     Text format     Abstract available

  58. RODRIGUEZ AC, Salmeron J
    Cervical cancer prevention in upper middle-income countries.
    Prev Med. 2017;98:36-38.
    PubMed     Text format     Abstract available


    Radiology

  59. JALAGUIER-COUDRAY A, Villard-Mahjoub R, Delouche A, Delarbre B, et al
    Value of Dynamic Contrast-enhanced and Diffusion-weighted MR Imaging in the Detection of Pathologic Complete Response in Cervical Cancer after Neoadjuvant Therapy: A Retrospective Observational Study.
    Radiology. 2017 Mar 14:161299. doi: 10.1148/radiol.2017161299.
    PubMed     Text format     Abstract available


    Recent Pat Anticancer Drug Discov

  60. QUDJANI E, Iman M, Davood A, Ramandi MF, et al
    Design and Synthesis of Curcumin-Like Diarylpentanoid Analogues as Potential Anticancer Agents.
    Recent Pat Anticancer Drug Discov. 2016;11:342-51.
    PubMed     Text format     Abstract available


    Sci Rep

  61. ZHANG R, Lu H, Lyu YY, Yang XM, et al
    E6/E7-P53-POU2F1-CTHRC1 axis promotes cervical cancer metastasis and activates Wnt/PCP pathway.
    Sci Rep. 2017;7:44744.
    PubMed     Text format     Abstract available


    Virus Genes

  62. LASZLO B, Ferenczi A, Madar L, Gyongyosi E, et al
    CpG methylation in human papillomavirus (HPV) type 31 long control region (LCR) in cervical infections associated with cytological abnormalities.
    Virus Genes. 2016;52:552-5.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: